Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin

被引：4

作者：

Bruno, S ^{[1
]}

Crosignani, A

Pinzello, GB

机构：

[1] S Paolo Univ Milan, I-20142 Milan, Italy

[2] Crespi Niguarda Hosp Milan, Liver Unit, I-20100 Milan, Italy

来源：

ANNALS OF INTERNAL MEDICINE | 2000年 / 133卷 / 11期

关键词：

D O I：

10.7326/0003-4819-133-11-200012050-00025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：922 / 923

页数：2

共 4 条

[1]

El-Zayadi A, 1999, ITAL J GASTROENTEROL, V31, P472

[2] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[3] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

[4] Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-α [J].

Zylberberg, H ;

Chaix, ML ;

Bréchot, C .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (10) :845-846

← 1 →